C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2011
03/10/2011	US20110059524 Human cdr-grafted antibody and antibody fragment thereof
03/10/2011	US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof
03/10/2011	US20110059507 Regulatable growth of filamentous fungi
03/10/2011	US20110059488 Anti-MPL Antibodies
03/10/2011	US20110059487 Engineered microorganisms and methods of use
03/10/2011	US20110059486 Non-splicing variants of gp350/220
03/10/2011	US20110059485 Plasmids from Thermophilic Organisms, Vectors Derived Therefrom, and Uses Thereof
03/10/2011	US20110059484 Process for producing polypeptides
03/10/2011	US20110059443 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift
03/10/2011	US20110059187 Peptide dicer substrate agents and methods for their specific inhibition of gene expression
03/10/2011	US20110059130 Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
03/10/2011	US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
03/10/2011	US20110059093 Use of an anti-tau ps422 antibody for the treatment of brain diseases
03/10/2011	US20110059091 Inhibitors of oncogenic isoforms and uses thereof
03/10/2011	US20110059090 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
03/10/2011	US20110059077 Humanized anti-human alpha 9-integrin antibody
03/10/2011	US20110059073 Method for treating infectious disease using monoclonal antibodies
03/10/2011	US20110059072 Method for treating cancer using monoclonal antibodies
03/10/2011	US20110059063 Antigen binding proteins that bind PAR-2
03/10/2011	US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins
03/10/2011	US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli
03/10/2011	CA2772653A1 Enhanced protein purification through a modified protein a elution
03/10/2011	CA2772628A1 Dual variable domain immunoglobulins and uses thereof
03/10/2011	CA2772613A1 Anti-gitr antibodies
03/10/2011	CA2772567A1 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
03/09/2011	EP2293067A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
03/09/2011	EP2292784A2 Enzymes having alpha amylase activity and methods of use thereof
03/09/2011	EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
03/09/2011	EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications
03/09/2011	EP2292763A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
03/09/2011	EP2292748A1 Method for producing gamma-carboxylated proteins
03/09/2011	EP2292662A2 Assay and reagents for quantifying hBNP
03/09/2011	EP2292652A2 Interferons uses and compositions related thereto
03/09/2011	EP2292301A2 Anti-interferon-alpha antibodies
03/09/2011	EP2292273A2 Remodeling and glycoconjugation of peptides
03/09/2011	EP2292271A2 Remodelling and glycoconjugation of an antibody
03/09/2011	EP2292256A2 High mannose proteins and methods of making high mannose proteins
03/09/2011	EP2292088A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
03/09/2011	EP2291536A2 Anti-psgl-1 antibodies and methods of identification and use
03/09/2011	EP2291535A1 Secretion-optimized microorganism
03/09/2011	EP2291534A1 Microorganism optimized for secretion
03/09/2011	EP1748069B1 Follistatin mutant polypeptide
03/09/2011	EP1583558B1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
03/09/2011	EP1364963B1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
03/09/2011	EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae)
03/09/2011	EP1276887B1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
03/09/2011	EP0994949B1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
03/09/2011	CN101983968A Preparation method of sepia oligopeptide by enzymatic hydrolysis and application thereof
03/09/2011	CN101173246B Medium for the protein-free and serum-free cultivation of cells
03/08/2011	US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly)
03/08/2011	US7902346 Fusion protein comprising FK506 binding protein and DNA encoding the same
03/08/2011	US7902338 Anti-CD19 antibodies
03/08/2011	US7902337 Isolated soybean cyst nematode and soybean sudden death syndrome polypeptides
03/08/2011	US7902336 Catecholamine regulated protein
03/08/2011	US7902335 Heat-stable recA mutant protein and a nucleic acid amplification method using the heat-stable recA mutant protein
03/08/2011	US7902334 Pesticidally active proteins and polynucleotides obtainable from Paenibacillus species
03/08/2011	US7901928 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts
03/08/2011	US7901924 Increased bacterial CoA and acetyl-CoA pools
03/08/2011	US7901919 Chimaeric phages
03/08/2011	US7901912 Method of producing uridine 5′-diphospho-N-acetylgalactosamine
03/08/2011	US7901909 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
03/08/2011	US7901908 Cell comprising vector coding stabilizing anti-repressor (STAR) sequences and bicistronic gene sequences for improving expression of heterologus gene
03/08/2011	US7901907 Process for production of Helicobacter pylori bacterioferritin
03/08/2011	US7901905 Gene expression system based on codon translation efficiency
03/08/2011	US7901900 quantitatively or qualitatively determine human low molecular weight CD14 with high sensitivity and specificity in a simple manner
03/08/2011	US7901892 Methods and compositions for determining the purity of chemically synthesized nucleic acids
03/08/2011	US7901718 Process for the extraction, purification and enzymatic modification of soy 7S globulin α′ subunit for use as hypocholesterolemizing agent
03/08/2011	US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
03/08/2011	US7901688 Rage fusion proteins
03/08/2011	US7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
03/08/2011	US7901680 Dock-and-lock (DNL) vaccines for cancer therapy
03/08/2011	US7901679 Humanized anti-ghrelin antibodies
03/08/2011	US7901670 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography
03/08/2011	CA2329054C A novel polypeptide hormone phosphatonin
03/08/2011	CA2240516C Novel tyrosine kinase receptors and ligands
03/08/2011	CA2137377C Retinal pigmented epithelium derived neurotrophic factor
03/03/2011	WO2011025962A1 Antikine antibodies that bind to multiple cc chemokines
03/03/2011	WO2011025904A1 Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof
03/03/2011	WO2011024887A1 Conjugate containing cyclic peptide and method for producing same
03/03/2011	WO2011023009A1 Recombinant expression of carboxylesterases
03/03/2011	WO2010150230A8 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
03/03/2011	WO2010124266A3 Thermostable cellulases, and mutants thereof, capable of hydrolyzing cellulose in ionic liquid
03/03/2011	WO2010111018A8 Antibody drug conjugates (adc) that bind to 24p4c12 proteins
03/03/2011	WO2010051049A3 Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
03/03/2011	US20110055942 Single domain TDF-related compounds and analogs thereof
03/03/2011	US20110055940 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use
03/03/2011	US20110055938 Transgenic animal for production of antibodies having minimal cdrs
03/03/2011	US20110054159 Rna interference mediating small rna molecules
03/03/2011	US20110054158 Polynucleotides encoding class ii cytokine receptor-7
03/03/2011	US20110054148 Antibodies to interferon-like protein zcyto21(il-29)
03/03/2011	US20110054027 Production of biofuel from tissue culture sources
03/03/2011	US20110053855 Ex vivo cell stimulation
03/03/2011	US20110053837 Mineral-peptide chelates
03/03/2011	US20110053791 Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen
03/03/2011	US20110053781 Methods and compositions for polypeptide engineering
03/03/2011	US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
03/03/2011	US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome
03/03/2011	US20110053245 Isomerases, nucleic acids encoding them and methods for making and using them
03/03/2011	US20110053225 Multifunctional tags
03/03/2011	US20110053224 Novel composition of matter and method for stimulating the growth of beneficial microorganisms

1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 1125